Page 382 - SRL Diagnostics Directory of Servies
P. 382

SR #      TEST NAME                              TAT

              93      Full sequencing of the ELA2 (ELANE) gene  4 - 6 WEEKS
              94      Full sequencing of the OTC gene        8 WEEKS
              95      Full sequencing of the TAZ gene        6 - 8 WEEKS
              96      Full sequencing of the TCN2 gene associated   4 - 6 WEEKS
                      with Transcobalamin II Deficiency
              97      Full UGT1A1 sequencing                 8 WEEKS
              98      genes (KCNA1 + CACNA1A) in a 113-gene   4 WEEKS
                      Ataxia/Episodic Ataxia panel
              99      GJB2 (connexion-26) + GJB6 common deletion only  8 WEEKS
              100     GLA gene associated with Fabry Disease  6 WEEKS
              101     GLA gene associated with Fabry Disease   4 WEEKS
              102     Gonadotropin Releasing Hormone         2 WEEKS
              103     Haemochromatosis (HFE Common mutations)   7 DAYS
              104     Haemolytic Uremic Syndrome/Macular Degeneration   6 - 8 WEEKS
                      (CFHR5 , CHFR1 , CHFR2 , CHFR3 , CHFR4)
              105     Haemolytic Uremic Syndrome/Macular     6 - 8 WEEKS
                      Degeneration panel that includes full NGS
                      sequencing + large deletion/duplication
              106     Hay-Wells Syndrome (p63) gene          6 WEEKS
              107     HBB GENE (LOCUS 11P, 15.4) ANALYSIS    3 - 4 WEEKS
              108     Hearing Loss NGS Panel 103 genes       8 WEEKS
              109     Helicobacter Pylori Antigen            3 DAYS
              110     Hereditary Cancer NGS Panel full sequencing   6 WEEKS
                      across 112 Genes+Deletion/Duplications
              111     Heroin Confirmation, Serum/Plasma/Whole blood  12 DAYS
              112     HIDS                                   6 WEEKS
              113     HLA-DRB1*04                            6 WEEKS
              114     HMGCL gene sanger sequencing           6 WEEKS
              115     Holotranscobalamin/ Active B12         7 DAYS
              116     Hyper-IgE Syndrome Panel               8 WEEKS
              117     Hyperinsulinemia (Gene panels: ABCC8, GCK,   4 - 6 WEEKS
                      GLUD1, HADH, HNF4A, INS, INSR, KCNJ11,
                      PDX1, SLC16A1, UCP2)
              118     IGF-1                                  7 - 10 DAYS
              119     IGVH mutation screening associated with   8 WEEKS
                      Chronic Lymphocytic Leukaemia (CLL)
              120     IGVH mutation screening associated with   4 WEEKS
                      Chronic Lymphocytic Leukaemia (CLL)
              121     IKBKG (NEMO) gene                      4 WEEKS
              122     Immunoglobulin G, subclasses           7 - 10 DAYS
              123     ITGA2B and ITGB3 genes associated with   6 - 8 WEEKS
                      Glanzmann Thrombasthenia
              124     K650T FGFR3 mutation associated with   4 WEEKS
                      Hypochondroplasia
   377   378   379   380   381   382   383   384   385   386   387